Cox J - Search Results

1

Dose intensity in lung cancer treatment.

Cox J, Ball D, Belani C, Choi N, Gralla R, Halle J, Komaki R, Le Chevalier T, Ohnoshi T, Quoix E, et al. Cox J, et al. Lung Cancer. 1994 Mar;10 Suppl 1:S11-3. doi: 10.1016/0169-5002(94)91661-6. Lung Cancer. 1994. PMID: 8087500 No abstract available.

2

Novel approaches to locally advanced unresectable non-small cell lung cancer.

Stevens CW, Lee JS, Cox J, Komaki R. Stevens CW, et al. Among authors: cox j. Radiother Oncol. 2000 Apr;55(1):11-8. doi: 10.1016/s0167-8140(00)00163-8. Radiother Oncol. 2000. PMID: 10788683 Review.

3

Radiation dose escalation in non-small cell carcinoma of the lung.

Arriagada R, Komaki R, Cox JD. Arriagada R, et al. Semin Radiat Oncol. 2004 Oct;14(4):287-91. doi: 10.1016/j.semradonc.2004.07.003. Semin Radiat Oncol. 2004. PMID: 15558502 Review. No abstract available.

4

Radiochemotherapy of esophageal cancer.

Liao Z, Cox JD, Komaki R. Liao Z, et al. J Thorac Oncol. 2007 Jun;2(6):553-68. doi: 10.1097/01.JTO.0000275339.62831.5e. J Thorac Oncol. 2007. PMID: 17545853 Free article. Review.

5

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer.

Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD. Sejpal S, et al. Cancer. 2011 Jul 1;117(13):3004-13. doi: 10.1002/cncr.25848. Epub 2011 Jan 24. Cancer. 2011. PMID: 21264827 Free article.

6

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.

Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Chang JY, et al. Cancer. 2011 Oct 15;117(20):4707-13. doi: 10.1002/cncr.26080. Epub 2011 Mar 22. Cancer. 2011. PMID: 21437893 Free PMC article. Clinical Trial.

7

FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy.

Xiang ZL, Erasmus J, Komaki R, Cox JD, Chang JY. Xiang ZL, et al. Among authors: cox jd. Radiat Oncol. 2012 Aug 28;7:144. doi: 10.1186/1748-717X-7-144. Radiat Oncol. 2012. PMID: 22929048 Free PMC article. Clinical Trial.

8

Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.

Suzuki R, Wei X, Allen PK, Cox JD, Komaki R, Lin SH. Suzuki R, et al. Clin Lung Cancer. 2019 Mar;20(2):117-123. doi: 10.1016/j.cllc.2018.11.013. Epub 2018 Nov 29. Clin Lung Cancer. 2019. PMID: 30611672

9

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Wang S, et al. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1399-407. doi: 10.1016/j.ijrobp.2006.07.1337. Epub 2006 Sep 25. Int J Radiat Oncol Biol Phys. 2006. PMID: 16997503

10

Staging classification committee.

Ginsberg R, Cox J, Green M, Bulzebruck H, Grunenwald D, Harper P, Jett J, LeChevalier T, Mornex F, Scott C, Tsuchiya R. Ginsberg R, et al. Among authors: cox j. Lung Cancer. 1997 Jun;17 Suppl 1:S11-3. doi: 10.1016/s0169-5002(97)00037-8. Lung Cancer. 1997. PMID: 9213296 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,805 results

Search Page

Filters